INUS
Straddle Chart

Markets / Mutual funds / Sectoral / Thematic

Mutual fundsSIF

WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth

NAVs of 8 Nov 2026

WhiteOak Capital Mutual Fund · Equity fund · Regular plan · Growth

Sectoral / ThematicRegular · GrowthRisk: Very High
NAV · 6 Nov 2026
₹17.0940 ▲ 0.71%
WhiteOak Capital Mutual Fund
Fund size₹858 crJuly - September 2026
1-month range₹15.47 – 17.09
1 year+20.80%rank 8 of 280
Expense ratio2.71%regular plan, a year
5 years–a year

What the fund does

To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.

BenchmarkBSE Healthcare TRI
Launched6 Feb 2024
Fund houseWhiteOak Capital Mutual Fund
Fund managersFM1 - Mr. Ramesh MantriFM2- Mr. Piyush BaranwalFM3 - Mr. Dheeresh PathakFM4 - Mr. Ashish AgrawalFM5 - Ms. Trupti Agrawal

NAV history

161617 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+2.78%avg 5.4%
1 month
+3.86%avg 2.9%
3 months
+2.22%avg -1.9%
6 months
+14.52%avg 3.1%
This year
+24.46%avg 3.2%
1 year
+20.80%avg 3.7% · #8/280

Bars: this plan; the thin mark is the Sectoral / Thematic average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+2.5
2025-4.9-9.0+8.8+0.3+1.5+3.6+5.1-2.8-1.8+4.5+1.0-3.5
2026-4.8+6.6-3.9+6.2+5.2+6.7+3.8+3.0-3.2+0.8+2.8

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Risk

Volatility13.8%yearly, from daily NAVs
Worst fall-15.28%3 Jan 2025 → 28 Feb 2025
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 9 Feb 2024).

Where it can invest (limits from the scheme document)

Equity & Equity related Instruments of Pharma and Healthcare companies
80–100%
Equity and Equity Related Instruments companies (including REITs) other than above
0–20%
Money Market Instruments##, Other Liquid Instruments^, Gold and Silver ETFs and units of Domestic Mutual Fund Schemes@
0–20%
Units issued by InvITs
0–10%

The ranges the fund is allowed to hold, not what it holds today.

Fund details

Fund size (average AUM, July - September 2026)₹858 cr across all plans · this plan ₹675 cr
Fund houseWhiteOak Capital Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanRegular
OptionGrowth
Expense ratio (TER)Direct 1.06% · Regular 2.71% (5 Nov 2026)
Minimum investment₹500 · additional ₹500
Scheme code (AMFI)152348
ISININF03VN01878
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · Growth₹17.9320+22.90%

Top Sectoral / Thematic funds (regular plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+37.70%+40.44%
HDFC Defence Fund+19.63%+33.69%
HDFC Pharma and Healthcare Fund+26.81%+30.17%
SBI HEALTHCARE OPPORTUNITIES FUND+21.11%+24.39%
HDFC Transportation and Logistics Fund+8.74%+23.82%
UTI - Healthcare Fund+17.70%+23.50%
Mirae Asset Healthcare Fund+22.57%+23.40%
BANK OF INDIA MANUFACTURING & INFRASTRUCTURE FUND+16.15%+22.19%
WhiteOak Capital Pharma and Healthcare Fund+20.80%–

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth today?

₹17.0940 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth?

1 year: 20.80%

How does WhiteOak Capital Pharma and Healthcare Fund rank in its category?

8 of 280 Sectoral / Thematic funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.